On the public citation graph

Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)

0 signed · 286 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/chin.200501165openalex-snapshot
Direct Reductive Alkylation of Amino Acids: Synthesis of Bifunctional Chelates for Nuclear Imaging.
inferredcites →https://doi.org/10.1002/cne.903150208openalex-snapshot
Immunocytochemical localization of the N‐acetyl‐aspartyl‐glutamate (NAAG) hydrolyzing enzyme N‐acetylated α‐linked acidic dipeptidase (NAALADase)
inferredcites →https://doi.org/10.1006/abio.1997.2413openalex-snapshot
A Long-Lived, Highly Luminescent Re(I) Metal–Ligand Complex as a Biomolecular Probe
inferredcites →https://doi.org/10.1007/s00259-004-1542-9openalex-snapshot
Is 11 C-choline the most appropriate tracer for prostate cancer?
inferredcites →https://doi.org/10.1007/s00259-004-1543-8openalex-snapshot
Is 11 C-choline the most appropriate tracer for prostate cancer?
inferredcites →https://doi.org/10.1007/s00259-006-0190-7openalex-snapshot
Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer
inferredcites →https://doi.org/10.1016/0006-2952(73)90196-2openalex-snapshot
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
inferredcites →https://doi.org/10.1016/j.ica.2005.11.022openalex-snapshot
A new bifunctional amino acid chelator targeting the glucose transporter
inferredcites →https://doi.org/10.1016/j.inoche.2004.07.006openalex-snapshot
A convenient synthesis, chemical characterization and reactivity of [Re(CO)3(H2O)3]Br: the crystal and molecular structure of [Re(CO)3(CH3CN)2Br]
inferredcites →https://doi.org/10.1016/j.jorganchem.2004.08.045openalex-snapshot
Organometallic 99mTc-technetium(I)- and Re-rhenium(I)-folate derivatives for potential use in nuclear medicine
inferredcites →https://doi.org/10.1016/j.nucmedbio.2004.09.001openalex-snapshot
New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design
inferredcites →https://doi.org/10.1016/s0021-9258(18)47823-4openalex-snapshot
Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain.
inferredcites →https://doi.org/10.1016/s0040-4039(00)91336-4openalex-snapshot
Selective removal of the -butyloxycarbonyl protecting group in the presence of t-butyl and p-methoxybenzyl esters
inferredcites →https://doi.org/10.1016/s0090-4295(00)01109-2openalex-snapshot
ProstaScint scan for staging prostate cancer
inferredcites →https://doi.org/10.1016/s0969-8051(00)00125-6openalex-snapshot
Column-switching HPLC for the analysis of plasma in PET imaging studies
inferredcites →https://doi.org/10.1021/ac970827kopenalex-snapshot
Use of a Long-Lifetime Re(I) Complex in Fluorescence Polarization Immunoassays of High-Molecular-Weight Analytes
inferredcites →https://doi.org/10.1021/bc0500591openalex-snapshot
A New Strategy for the Preparation of Peptide-Targeted Technetium and Rhenium Radiopharmaceuticals. The Automated Solid-Phase Synthesis, Characterization, Labeling, and Screening of a Peptide-Ligand Library Targeted at the Formyl Peptide Receptor
inferredcites →https://doi.org/10.1021/bc050298oopenalex-snapshot
Isostructural Re and 99mTc Complexes of Biotin Derivatives for Fluorescence and Radioimaging Studies
inferredcites →https://doi.org/10.1021/bc990174+openalex-snapshot
Synthesis and Characterization of a Sulfhydryl-Reactive Rhenium Metal−Ligand Complex
inferredcites →https://doi.org/10.1021/ic020391dopenalex-snapshot
{ReIIICl3} Core Complexes with Bifunctional Single Amino Acid Chelates
inferredcites →https://doi.org/10.1021/j100678a001openalex-snapshot
Measurement of photoluminescence quantum yields. Review
inferredcites →https://doi.org/10.1021/ja003932bopenalex-snapshot
Synthesis and Properties of Boranocarbonate: A Convenient in Situ CO Source for the Aqueous Preparation of [99mTc(OH2)3(CO)3]+
inferredcites →https://doi.org/10.1021/ja0043183openalex-snapshot
Properties of Photogenerated Tryptophan and Tyrosyl Radicals in Structurally Characterized Proteins Containing Rhenium(I) Tricarbonyl Diimines
inferredcites →https://doi.org/10.1021/ja047751bopenalex-snapshot
Bridging the Gap between in Vitro and in Vivo Imaging: Isostructural Re and 99m Tc Complexes for Correlating Fluorescence and Radioimaging Studies
inferredcites →https://doi.org/10.1021/ja980745topenalex-snapshot
A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules: Synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in Aqueous Solution and Its Reaction with a Bifunctional Ligand
inferredcites →https://doi.org/10.1021/jm000406mopenalex-snapshot
Design of Remarkably Simple, Yet Potent Urea-Based Inhibitors of Glutamate Carboxypeptidase II (NAALADase)
inferredcites →https://doi.org/10.1021/jm00221a015openalex-snapshot
Antibacterial halogenoacetyl derivatives of amino acids and simple peptides
inferredcites →https://doi.org/10.1021/jm070133wopenalex-snapshot
Structural Insight into the Pharmacophore Pocket of Human Glutamate Carboxypeptidase II
inferredcites →https://doi.org/10.1021/jm950801qopenalex-snapshot
Design, Synthesis, and Biological Activity of a Potent Inhibitor of the Neuropeptidase N-Acetylated α-Linked Acidic Dipeptidase
inferredcites →https://doi.org/10.1021/jm9905559openalex-snapshot
Dual Function Glutamate-Related Ligands: Discovery of a Novel, Potent Inhibitor of Glutamate Carboxypeptidase II Possessing mGluR3 Agonist Activity
inferredcites →https://doi.org/10.1038/nrd1903openalex-snapshot
NAAG peptidase inhibitors and their potential for diagnosis and therapy
inferredcites →https://doi.org/10.1038/sj.emboj.7600969openalex-snapshot
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
inferredcites →https://doi.org/10.1038/sj.gt.3302721openalex-snapshot
Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate
inferredcites →https://doi.org/10.1039/b306914aopenalex-snapshot
Luminescent rhenium( i ) diimine indole conjugates – photophysical, electrochemical and protein-binding properties
inferredcites →https://doi.org/10.1039/b417588copenalex-snapshot
Site directed maleimide bifunctional chelators for the M(CO)3+ core (M =99mTc, Re)
inferredcites →https://doi.org/10.1053/j.semnuclmed.2006.07.002openalex-snapshot
Synergistic Value of Single-Photon Emission Computed Tomography/Computed Tomography Fusion to Radioimmunoscintigraphic Imaging of Prostate Cancer
inferredcites →https://doi.org/10.1071/ch9721293openalex-snapshot
A convenient preparative method for esters of amino acids
inferredcites →https://doi.org/10.1071/ch9781865openalex-snapshot
Some amino acid esters– An improved preparative method
inferredcites →https://doi.org/10.1073/pnas.1735443100openalex-snapshot
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
inferredcites →https://doi.org/10.1089/cbr.2000.15.131openalex-snapshot
Capromab Pendetide Imaging of Prostate Cancer
inferredcites →https://doi.org/10.1091/mbc.e02-11-0731openalex-snapshot
A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen
inferredcites →https://doi.org/10.1107/s090744490700902xopenalex-snapshot
Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA
inferredcites →https://doi.org/10.1107/s174430910700379xopenalex-snapshot
A high-resolution structure of ligand-free human glutamate carboxypeptidase II
inferredcites →https://doi.org/10.1111/j.1464-410x.2005.05511.xopenalex-snapshot
Imaging with radiolabelled monoclonal antibody (MUJ591) to prostate‐specific membrane antigen in staging of clinically localized prostatic carcinoma: comparison with clinical, surgical and histological staging
inferredcites →https://doi.org/10.1111/j.1464-410x.2007.06772.xopenalex-snapshot
18 F‐choline and/or 11 C‐acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate‐specific antigen values (<1 ng/mL) after radical prostatectomy
inferredcites →https://doi.org/10.1111/j.1464-410x.2007.07083.xopenalex-snapshot
Evaluation of [ 11 C]‐choline positron‐emission/computed tomography in patients with increasing prostate‐specific antigen levels after primary treatment for prostate cancer
inferredcites →https://doi.org/10.1111/j.1742-4658.2007.06021.xopenalex-snapshot
Mapping of the active site of glutamate carboxypeptidase II by site‐directed mutagenesis
inferredcites →https://doi.org/10.1158/1078-0432.ccr-04-2690openalex-snapshot
Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen:In vivoImaging in Experimental Models of Prostate Cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-07-1517openalex-snapshot
N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl- l -Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer
inferredcites →https://doi.org/10.1162/153535002320162750openalex-snapshot
11C-MCG: Synthesis, Uptake Selectivity, and Primate PET of a Probe for Glutamate Carboxypeptidase II (NAALADase)
inferredcites →https://doi.org/10.1200/jco.2006.07.8097openalex-snapshot
Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors
inferredcites →https://doi.org/10.1246/bcsj.55.2697openalex-snapshot
Synthesis, Luminescence Quantum Yields, and Lifetimes of Trischelated Ruthenium(II) Mixed-ligand Complexes Including 3,3′-Dimethyl-2,2′-bipyridyl
inferredcites →https://doi.org/10.14494/jnrs2000.6.3_153openalex-snapshot
Synthesis, Structure, and Spectroscopic Properties of fac-[TcICl(CO)3(bpy)] (bpy=2, 2'-bipyridine)
inferredcites →https://doi.org/10.1615/critrevimmunol.v21.i1-3.160openalex-snapshot
A Unique Folate Hydrolase, Prostate-Specific Membrane Antigen (PSMA): A Target For Immunotherapy?
inferredcites →https://doi.org/10.2967/jnumed.107.042762openalex-snapshot
Tumor Imaging Using 1-(2'-deoxy-2'-18F- Fluoro- -D-Arabinofuranosyl)Thymine and PET
inferredcites →https://doi.org/10.3322/canjclin.53.1.5openalex-snapshot
Cancer Statistics, 2003

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4996194openalex-extracted
Synthesis and Study of Hynic Conjugated Psma Targeting Ligands for Prostate Cancer Diagnosis
inferred← citeshttps://doi.org/10.1002/9780470508169.ch36openalex-snapshot
Recent Development of Diagnostic and Therapeutic Agents Targeting Glutamate Carboxypeptidase II (GCPII)
inferred← citeshttps://doi.org/10.1002/9781119500575.ch12openalex-snapshot
99m Tc Radiopharmaceutical Chemistry
inferred← citeshttps://doi.org/10.1002/9781119500575.ch9openalex-snapshot
Labeling with Gallium‐68
inferred← citeshttps://doi.org/10.1002/9783527814923.ch13openalex-snapshot
Probes for Medical Imaging
inferred← citeshttps://doi.org/10.1002/9783527827855.ch11openalex-snapshot
Metal Complexes as the Means or the End of Targeted Delivery for Unmet Needs
inferred← citeshttps://doi.org/10.1002/ajoc.201900329openalex-snapshot
Prostate‐Specific Membrane Antigen (PSMA)‐Targeted Radionuclide Probes for Imaging and Therapy of Prostate Cancer
inferred← citeshttps://doi.org/10.1002/ange.201102872openalex-snapshot
Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate‐Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1002/ange.201503417openalex-snapshot
Synthesis and Evaluation of GdIII‐Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate‐Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1002/ange.201908964openalex-snapshot
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention
inferred← citeshttps://doi.org/10.1002/anie.201102872openalex-snapshot
Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate‐Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1002/anie.201503417openalex-snapshot
Synthesis and Evaluation of GdIII‐Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate‐Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1002/anie.201908964openalex-snapshot
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention
inferred← citeshttps://doi.org/10.1002/btpr.3366openalex-snapshot
Aptamer‐functionalized quantum dots as theranostic nanotools against cancer and bacterial infections: A comprehensive overview of recent trends
inferred← citeshttps://doi.org/10.1002/chem.201903390openalex-snapshot
Modular Synthesis of DOTA‐Metal‐Based PSMA‐Targeted Imaging Agents for MRI and PET of Prostate Cancer
inferred← citeshttps://doi.org/10.1002/cnr2.1169openalex-snapshot
Comparison of prostate‐specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer
inferred← citeshttps://doi.org/10.1002/jlcr.1547openalex-snapshot
Current Awareness in Labelled Compounds and Radiopharmaceuticals
inferred← citeshttps://doi.org/10.1002/jlcr.3164openalex-snapshot
Single amino acid chelate complexes of the M(CO)3+ core for correlating fluorescence and radioimaging studies (M = 99mTc or Re)
inferred← citeshttps://doi.org/10.1002/jlcr.3430openalex-snapshot
An improved synthesis of the radiolabeled prostate‐specific membrane antigen inhibitor, [18F]DCFPyL
inferred← citeshttps://doi.org/10.1002/jlcr.3531openalex-snapshot
Technetium‐99m radiochemistry for pharmaceutical applications
inferred← citeshttps://doi.org/10.1002/jlcr.3621openalex-snapshot
Imaging prostate cancer (PCa) with [99mTc(CO)3]finasteride dithiocarbamate
inferred← citeshttps://doi.org/10.1002/macp.201700440openalex-snapshot
Conjugated Polymer‐Based Nanoparticles for Cancer Cell‐Targeted and Image‐Guided Photodynamic Therapy
inferred← citeshttps://doi.org/10.1002/med.20161openalex-snapshot
Angiogenesis as a strategic target for prostate cancer therapy
inferred← citeshttps://doi.org/10.1002/med.21508openalex-snapshot
Targeting prostate cancer: Prostate‐specific membrane antigen based diagnosis and therapy
inferred← citeshttps://doi.org/10.1002/pros.20909openalex-snapshot
In vitro targeted photodynamic therapy with a pyropheophorbide‐a conjugated inhibitor of prostate‐specific membrane antigen
inferred← citeshttps://doi.org/10.1002/pros.21413openalex-snapshot
Imaging prostate cancer lymph node metastases with a multimodality contrast agent
inferred← citeshttps://doi.org/10.1002/pros.21493openalex-snapshot
A phosphoramidate‐based prostate‐specific membrane antigen‐targeted SPECT agent
inferred← citeshttps://doi.org/10.1002/pros.22789openalex-snapshot
Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker
inferred← citeshttps://doi.org/10.1002/pros.22956openalex-snapshot
Prostate‐specific membrane antigen‐based imaging in prostate cancer: Impact on clinical decision making process
inferred← citeshttps://doi.org/10.1002/pros.23115openalex-snapshot
Characterization of a novel metastatic prostate cancer cell line of LNCaP origin
inferred← citeshttps://doi.org/10.1002/pros.23642openalex-snapshot
Meeting report from the Prostate Cancer Foundation PSMA‐directed radionuclide scientific working group
inferred← citeshttps://doi.org/10.1007/978-1-4939-1176-9_4openalex-snapshot
New Imaging Modalities
inferred← citeshttps://doi.org/10.1007/978-1-61779-027-0_25openalex-snapshot
Integrated Bioinformatics Analysis for Cancer Target Identification
inferred← citeshttps://doi.org/10.1007/978-3-030-65245-6_4openalex-snapshot
Fundamentals of Technetium-99m Radiopharmaceutical Chemistry
inferred← citeshttps://doi.org/10.1007/978-3-031-39005-0_17openalex-snapshot
Small Molecules as Vectors for Radiopharmaceutical Therapy
inferred← citeshttps://doi.org/10.1007/978-3-319-98947-1_18openalex-snapshot
The Radiopharmaceutical Chemistry of Technetium-99m
inferred← citeshttps://doi.org/10.1007/s00259-012-2298-2openalex-snapshot
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
inferred← citeshttps://doi.org/10.1007/s00259-013-2525-5openalex-snapshot
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
inferred← citeshttps://doi.org/10.1007/s00259-013-2527-3openalex-snapshot
Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer
inferred← citeshttps://doi.org/10.1007/s00259-015-3186-3openalex-snapshot
Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks
inferred← citeshttps://doi.org/10.1007/s00259-019-04434-0openalex-snapshot
177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy
inferred← citeshttps://doi.org/10.1007/s00259-020-05169-zopenalex-snapshot
[18F]-JK-PSMA-7 and [18F]-FDG tumour PET uptake in treated xenograft human prostate cancer model in mice
inferred← citeshttps://doi.org/10.1007/s11307-010-0353-6openalex-snapshot
Biodistribution and Clearance of Small Molecule Hapten Chelates for Pretargeted Radioimmunotherapy
inferred← citeshttps://doi.org/10.1007/s11307-015-0908-7openalex-snapshot
Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer
inferred← citeshttps://doi.org/10.1007/s11307-016-0942-0openalex-snapshot
Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [177Lu]DKFZ-PSMA-617
inferred← citeshttps://doi.org/10.1007/s11307-019-01318-5openalex-snapshot
Imaging and Characterization of Macrophage Distribution in Mouse Models of Human Prostate Cancer
inferred← citeshttps://doi.org/10.1007/s11307-023-01857-yopenalex-snapshot
Alpha Particle–Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery
inferred← citeshttps://doi.org/10.1007/s13233-013-1050-5openalex-snapshot
Synthesis and biological evaluation of substrate-based imaging agents for the prostate-specific membrane antigen
inferred← citeshttps://doi.org/10.1007/s40134-013-0020-1openalex-snapshot
Translational Molecular Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-12-411638-2.00004-5openalex-snapshot
Molecular-Genetic Imaging of Cancer
inferred← citeshttps://doi.org/10.1016/b978-0-323-85650-8.00010-3openalex-snapshot
Revolutionizing medical diagnosis with SPECT imaging: Clinical applications of a nuclear imaging technology
inferred← citeshttps://doi.org/10.1016/j.apradiso.2012.10.014openalex-snapshot
The untapped potential of Gallium 68-PET: The next wave of 68Ga-agents
inferred← citeshttps://doi.org/10.1016/j.bbrc.2009.10.017openalex-snapshot
A low molecular weight PSMA-based fluorescent imaging agent for cancer
inferred← citeshttps://doi.org/10.1016/j.bbrc.2023.02.003openalex-snapshot
Evaluation of PSMA target diagnostic PET tracers for therapeutic monitoring of [177Lu]ludotadipep of prostate cancer: Screening of PSMA target efficiency and biodistribution using [18F]DCFPyL and [68Ga]PSMA-11
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2015.11.048openalex-snapshot
PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2018.08.062openalex-snapshot
A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.103743openalex-snapshot
Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104304openalex-snapshot
Structure-activity relationship studies of prostate-specific membrane antigen (PSMA) inhibitors derived from α-amino acid with (S)- or (R)-configuration at P1′ region
inferred← citeshttps://doi.org/10.1016/j.bioorg.2022.106145openalex-snapshot
Chemical synthesis of fluorinated and iodinated 17β-HSD3 inhibitors and evaluation for imaging prostate cancer tumors and tissue biodistribution
inferred← citeshttps://doi.org/10.1016/j.bmcl.2009.10.061openalex-snapshot
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studies
inferred← citeshttps://doi.org/10.1016/j.bmcl.2012.09.014openalex-snapshot
Synthesis and SAR of 99mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates
inferred← citeshttps://doi.org/10.1016/j.bmcl.2015.09.062openalex-snapshot
Carborane-containing urea-based inhibitors of glutamate carboxypeptidase II: Synthesis and structural characterization
inferred← citeshttps://doi.org/10.1016/j.ccr.2019.04.014openalex-snapshot
Organometallic and coordination rhenium compounds and their potential in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2022.214911openalex-snapshot
Technetium(I) carbonyl complexes for nuclear medicine: Coordination-chemical aspect
inferred← citeshttps://doi.org/10.1016/j.chembiol.2015.12.003openalex-snapshot
A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application
inferred← citeshttps://doi.org/10.1016/j.cpet.2016.12.004openalex-snapshot
Gallium-68 Prostate-Specific Membrane Antigen PET Imaging
inferred← citeshttps://doi.org/10.1016/j.drudis.2013.06.008openalex-snapshot
Progress using Tc-99m radiopharmaceuticals for measuring high capacity sites and low density sites
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.04.033openalex-snapshot
Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115659openalex-snapshot
A cell-impermeable luminogenic probe for near-infrared imaging of prostate-specific membrane antigen in prostate cancer microenvironments
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115925openalex-snapshot
Synthesis and clinical application of small-molecule drugs approved to treat prostatic cancer
inferred← citeshttps://doi.org/10.1016/j.ica.2012.03.002openalex-snapshot
Small molecule inhibitors of PSMA incorporating technetium-99m for imaging prostate cancer: Effects of chelate design on pharmacokinetics
inferred← citeshttps://doi.org/10.1016/j.ica.2020.119807openalex-snapshot
Effect of the triphenylphosphonium cation on the biological properties of new rhenium and technetium-99m fac-[M(CO)3(NSN)]±-type complexes: Synthesis, structural characterization, in vitro and in vivo studies
inferred← citeshttps://doi.org/10.1016/j.jinorgbio.2010.06.011openalex-snapshot
Preparation, 99mTc-labeling and biodistribution studies of a PNA oligomer containing a new ligand derivative of 2,2′-dipicolylamine
inferred← citeshttps://doi.org/10.1016/j.jphotochem.2019.04.034openalex-snapshot
Separation of Re(VII) from aqueous solution by acetone-enhanced photoreduction: an insight into the role of acetone
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2014.01.001openalex-snapshot
Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2015.06.003openalex-snapshot
A high-affinity [18F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2016.08.006openalex-snapshot
Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2020.04.005openalex-snapshot
Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2020.06.005openalex-snapshot
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy
inferred← citeshttps://doi.org/10.1016/j.ucl.2018.03.016openalex-snapshot
Advances in Urologic Imaging
inferred← citeshttps://doi.org/10.1021/acs.analchem.6b03959openalex-snapshot
Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium
inferred← citeshttps://doi.org/10.1021/acs.analchem.7b02016openalex-snapshot
Near-Infrared Neodymium Tag for Quantifying Targeted Biomarker and Counting Its Host Circulating Tumor Cells
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.1c00537openalex-snapshot
Strain-Promoted Azide–Alkyne Cycloaddition-Based PSMA-Targeting Ligands for Multimodal Intraoperative Tumor Detection of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.5b00679openalex-snapshot
Preclinical Comparative Study of 68Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.6b00222openalex-snapshot
Design of a Small-Molecule Drug Conjugate for Prostate Cancer Targeted Theranostics
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.9b00758openalex-snapshot
Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers?
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00291openalex-snapshot
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01785openalex-snapshot
Development of Heterobivalent Theranostic Probes Having High Affinity/Selectivity for the GRPR/PSMA
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00444openalex-snapshot
Visualizing Tumors in Real Time: A Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c02767openalex-snapshot
Development of [ 99m Tc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01210openalex-snapshot
Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01268openalex-snapshot
[ 18 F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA)
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01850openalex-snapshot
Structure–Activity Relationship of 18F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00370openalex-snapshot
Development of Novel Radiotheranostic Ligand with Positively Charged Unit Targeting Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c00735openalex-snapshot
Synthesis and Evaluation of Novel C-X-C Chemokine Receptor 4-Targeted Radiotracers for Oncological Imaging
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c01593openalex-snapshot
How a Medicinal Chemistry Project Changed the Way Prostate Cancer is Diagnosed and Treated
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b02022openalex-snapshot
Novel β- and γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.3c00787openalex-snapshot
Synthesis and Preclinical Evaluation of PSMA-Targeted 111In-Radioconjugates Containing a Mitochondria-Tropic Triphenylphosphonium Carrier
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.9b00464openalex-snapshot
Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy
inferred← citeshttps://doi.org/10.1021/bc3003919openalex-snapshot
Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1021/bc4005377openalex-snapshot
Heterobivalent Agents Targeting PSMA and Integrin-αvβ3
inferred← citeshttps://doi.org/10.1021/bc5000115openalex-snapshot
Clickable, Hydrophilic Ligand for fac- [MI(CO)3]+ (M = Re/99mTc) Applied in an S -Functionalized α-MSH Peptide
inferred← citeshttps://doi.org/10.1021/bc500362nopenalex-snapshot
Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer
inferred← citeshttps://doi.org/10.1021/jacs.1c07377openalex-snapshot
Magnetic Resonance Imaging of PSMA-Positive Prostate Cancer by a Targeted and Activatable Gd(III) MR Contrast Agent
inferred← citeshttps://doi.org/10.1021/jm100623eopenalex-snapshot
68 Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
inferred← citeshttps://doi.org/10.1021/jm1013715openalex-snapshot
Targeted Biocompatible Nanoparticles for the Delivery of (−)-Epigallocatechin 3-Gallate to Prostate Cancer Cells
inferred← citeshttps://doi.org/10.1021/jm300710jopenalex-snapshot
Radiofluorinated Derivatives of 2-(Phosphonomethyl)pentanedioic Acid as Inhibitors of Prostate Specific Membrane Antigen (PSMA) for the Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/jm400823wopenalex-snapshot
Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA)
inferred← citeshttps://doi.org/10.1021/jm400895sopenalex-snapshot
Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging
inferred← citeshttps://doi.org/10.1021/jm401921jopenalex-snapshot
64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1021/jm801033copenalex-snapshot
Multivalent Scaffolds for Affinity Maturation of Small Molecule Cell Surface Binders and Their Application to Prostate Tumor Targeting
inferred← citeshttps://doi.org/10.1021/jm801055hopenalex-snapshot
Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer
inferred← citeshttps://doi.org/10.1021/mp100360gopenalex-snapshot
Development of Polymeric Microbubbles Targeted to Prostate-Specific Membrane Antigen as Prototype of Novel Ultrasound Contrast Agents
inferred← citeshttps://doi.org/10.1021/mp4000844openalex-snapshot
A Multivalent Approach of Imaging Probe Design To Overcome an Endogenous Anion Binding Competition for Noninvasive Assessment of Prostate Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1021/mp900069dopenalex-snapshot
Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand
inferred← citeshttps://doi.org/10.1021/mp9000712openalex-snapshot
Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents
inferred← citeshttps://doi.org/10.1038/mtna.2016.43openalex-snapshot
A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo
inferred← citeshttps://doi.org/10.1038/scibx.2009.691openalex-snapshot
Microscopic look at prostate cancer
inferred← citeshttps://doi.org/10.1039/9781849733151-00062openalex-snapshot
Glutamate Carboxypeptidase II as a Therapeutic Target
inferred← citeshttps://doi.org/10.1039/c1dt10379bopenalex-snapshot
Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals
inferred← citeshttps://doi.org/10.1039/c2ob07118eopenalex-snapshot
Dipicolylamine as a unique structural switching element for helical peptides
inferred← citeshttps://doi.org/10.1039/c4nr06069eopenalex-snapshot
Evaluation of a PSMA-targeted BNF nanoparticle construct
inferred← citeshttps://doi.org/10.1039/c6cc09781bopenalex-snapshot
PSMA-targeted contrast agents for intraoperative imaging of prostate cancer,
inferred← citeshttps://doi.org/10.1039/c6sc01739hopenalex-snapshot
Ultrahigh affinity Raman probe for targeted live cell imaging of prostate cancer
inferred← citeshttps://doi.org/10.1039/c8nj06006aopenalex-snapshot
Target exploration of rhein as a small-molecule necrosis avid agent by post-treatment click modification
inferred← citeshttps://doi.org/10.1039/d3tb02543hopenalex-snapshot
Pretargeted radiotherapy and synergistic treatment of metastatic, castration-resistant prostate cancer using cross-linked, PSMA-targeted lipoic acid nanoparticles
inferred← citeshttps://doi.org/10.1039/d4cp04137bopenalex-snapshot
Balancing enthalpy and entropy in inhibitor binding to the prostate-specific membrane antigen (PSMA)
inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2013.10.008openalex-snapshot
Molecular Imaging of Urogenital Diseases
inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2016.04.004openalex-snapshot
Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer
inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2023.06.007openalex-snapshot
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer
inferred← citeshttps://doi.org/10.1055/a-2854-0411openalex-snapshot
Amino Acid-Derived Isocyanates: A Comprehensive Review of Synthesis, Reactivity, and Stability
inferred← citeshttps://doi.org/10.1055/s-0045-1809921openalex-snapshot
A New Labeling Method of 99mTc-PSMA-HBED-CC
inferred← citeshttps://doi.org/10.1080/15257770.2012.671988openalex-snapshot
Structure-Activity Relationships of 2′,5′-Oligoadenylate Analogue Modifications of Prostate-Specific Membrane Antigen (PSMA) Antagonists
inferred← citeshttps://doi.org/10.1093/carcin/bgx141openalex-snapshot
Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities
inferred← citeshttps://doi.org/10.1097/cco.0b013e3283373d5copenalex-snapshot
‘Image and treat’: an individualized approach to urological tumors
inferred← citeshttps://doi.org/10.1097/mnm.0000000000001361openalex-snapshot
Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality
inferred← citeshttps://doi.org/10.1097/mnm.0000000000002075openalex-snapshot
Intraindividual comparison of 99mTc-HYNIC-PSMA-11 and 99mTc-MDP bone scan with SPECT/CT for detecting skeletal metastases in prostate cancer: a prospective concordance study
inferred← citeshttps://doi.org/10.1097/rlu.0000000000001176openalex-snapshot
Widespread Metastatic Prostate Carcinoma Shown by 68Ga-PSMA PET/CT
inferred← citeshttps://doi.org/10.1097/rlu.0000000000001316openalex-snapshot
Demonstration of Response to Androgen Deprivation Therapy by 68Ga-PSMA PET/CT
inferred← citeshttps://doi.org/10.1101/2024.10.31.621442openalex-snapshot
A New Labelling Method of 99m Tc-PSMA-HBED-CC
inferred← citeshttps://doi.org/10.1111/cbdd.13946openalex-snapshot
The utility of radiolabeled PSMA ligands for tumor imaging
inferred← citeshttps://doi.org/10.1111/j.1747-0285.2011.01085.xopenalex-snapshot
N‐Substituted Glutamyl Sulfonamides as Inhibitors of Glutamate Carboxypeptidase II (GCP2)
inferred← citeshttps://doi.org/10.1134/s1995078020040023openalex-snapshot
Rhenium Radioisotopes: Production, Properties, and Targeted Delivery Using Nanostructures
inferred← citeshttps://doi.org/10.1146/annurev-med-062117-073027openalex-snapshot
Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications
inferred← citeshttps://doi.org/10.1155/2014/104248openalex-snapshot
Pharmacokinetic and Biodistribution Assessment of a Near Infrared-Labeled PSMA-Specific Small Molecule in Tumor-Bearing Mice
inferred← citeshttps://doi.org/10.1158/0008-5472.can-09-1682openalex-snapshot
Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.c.6532503.v1openalex-snapshot
Data from Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-11-1357openalex-snapshot
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-21-4531openalex-snapshot
Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-14-0422openalex-snapshot
Development of Targeted Near-Infrared Imaging Agents for Prostate Cancer
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-14-0744openalex-snapshot
Protease-Activated Pore-Forming Peptides for the Treatment and Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-15-0722openalex-snapshot
Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.11606/d.85.2016.tde-30112016-103604openalex-snapshot
Estudo de radiomarcação com gálio-68 do inibidor de PSMA baseado em ureia - avaliação comparativa de método automatizado e não automatizado
inferred← citeshttps://doi.org/10.11606/d.85.2017.tde-07122017-110519openalex-snapshot
Radiomarcação de inibidor de PSMA com 177Lu e avaliação biológica do potencial para aplicação no tratamento do câncer de próstata
inferred← citeshttps://doi.org/10.1177/0192623310390392openalex-snapshot
Continuing Education Course #1
inferred← citeshttps://doi.org/10.1177/1536012117737010openalex-snapshot
Radiochemistry and Preclinical PET Imaging of 68 Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1186/2191-219x-2-23openalex-snapshot
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer
inferred← citeshttps://doi.org/10.1186/s13550-014-0063-1openalex-snapshot
Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
inferred← citeshttps://doi.org/10.1186/s41181-025-00389-wopenalex-snapshot
Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modifications
inferred← citeshttps://doi.org/10.1259/bjr.20150256openalex-snapshot
Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy
inferred← citeshttps://doi.org/10.1371/journal.pone.0068339openalex-snapshot
Evaluation of Phage Display Discovered Peptides as Ligands for Prostate-Specific Membrane Antigen (PSMA)
inferred← citeshttps://doi.org/10.1371/journal.pone.0145755openalex-snapshot
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors
inferred← citeshttps://doi.org/10.1515/ract-2017-2874openalex-snapshot
Production, quality control, biodistribution and imaging studies of 177Lu-PSMA-617 in breast adenocarcinoma model
inferred← citeshttps://doi.org/10.1515/ract-2025-0038openalex-snapshot
Synthesis and radiolabelling studies of hynic conjugated PSMA targeting ligands
inferred← citeshttps://doi.org/10.15415/jnp.2015.31001openalex-snapshot
Nuclei Near and Far From β -Stability Line
inferred← citeshttps://doi.org/10.1557/mrs2009.119openalex-snapshot
Nanoparticle Delivery: Targeting and Nonspecific Binding
inferred← citeshttps://doi.org/10.15690/vramn2207openalex-snapshot
99mTc-Labelled Low Molecular Weight Inhibitors of Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.1586/erm.09.73openalex-snapshot
Putative molecular signatures for the imaging of prostate cancer
inferred← citeshttps://doi.org/10.1594/ecr2012/b-0970openalex-snapshot
Evaluation in vitro of new polymeric contrast microbubbles using Qontrast software
inferred← citeshttps://doi.org/10.18632/oncotarget.415openalex-snapshot
A Modular Strategy to Prepare Multivalent Inhibitors of Prostate-Specific Membrane Antigen (PSMA)
inferred← citeshttps://doi.org/10.21037/atm-20-6191openalex-snapshot
Artificial intelligence in molecular imaging
inferred← citeshttps://doi.org/10.21037/tau.2019.07.20openalex-snapshot
Prostate specific membrane antigen (PSMA) imaging: the past is prologue
inferred← citeshttps://doi.org/10.21236/ada547550openalex-snapshot
New Imaging Strategies for Prostate Cancer
inferred← citeshttps://doi.org/10.21236/ada549277openalex-snapshot
Heterobivalent Imaging Agents for Simultaneous Targeting Prostate-Specific Membrane Antigen (PSMA) and Hepsin
inferred← citeshttps://doi.org/10.2174/0118744710293461240219111852openalex-snapshot
“One Method to Label Them All”: A Single Fully Automated Protocol for GMP-Compliant 68Ga Radiolabeling of PSMA-11, Transposable to PSMA-I&T and PSMA-617
inferred← citeshttps://doi.org/10.2174/092986712799034888openalex-snapshot
Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
inferred← citeshttps://doi.org/10.2174/092986712799462612openalex-snapshot
GCPII Imaging and Cancer
inferred← citeshttps://doi.org/10.2174/092986712799462667openalex-snapshot
Glutamate Carboxypeptidase II: An Overview of Structural Studies and Their Importance for Structure-Based Drug Design and Deciphering the Reaction Mechanism of the Enzyme
inferred← citeshttps://doi.org/10.2174/0929867327666200504082256openalex-snapshot
In Silico Modelling in the Development of Novel Radiolabelled Peptide Probes
inferred← citeshttps://doi.org/10.2174/0929867327666201006153847openalex-snapshot
Evolution of Peptide-Based Prostate-Specific Membrane Antigen (PSMA) Inhibitors: An Approach to Novel Prostate Cancer Therapeutics
inferred← citeshttps://doi.org/10.2174/1381612826666200721001500openalex-snapshot
Nanoparticles for Targeting of Prostate Cancer
inferred← citeshttps://doi.org/10.2174/156802610791384225openalex-snapshot
Design and Development of Molecular Imaging Probes
inferred← citeshttps://doi.org/10.2174/1568026611313080008openalex-snapshot
PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.2174/1573405615666190225155254openalex-snapshot
Comparison of Bone Uptake in Bone Scan and Ga-68 PSMA PET/CT Images in Patients with Prostate Cancer
inferred← citeshttps://doi.org/10.2174/1874471012666190729151540openalex-snapshot
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
inferred← citeshttps://doi.org/10.2214/ajr.09.2579openalex-snapshot
Challenges in Clinical Prostate Cancer: Role of Imaging
inferred← citeshttps://doi.org/10.2214/ajr.18.19957openalex-snapshot
Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications
inferred← citeshttps://doi.org/10.2310/7290.2009.00010openalex-snapshot
Molecular Imaging of Prostate Cancer: A Concise Synopsis
inferred← citeshttps://doi.org/10.2310/7290.2010.00024openalex-snapshot
General Approach to Identifying Potential Targets for Cancer Imaging by Integrated Bioinformatics Analysis of Publicly Available Genomic Profiles
inferred← citeshttps://doi.org/10.2967/jnumed.109.061838openalex-snapshot
New Agents and Techniques for Imaging Prostate Cancer
inferred← citeshttps://doi.org/10.2967/jnumed.109.066589openalex-snapshot
Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer
inferred← citeshttps://doi.org/10.2967/jnumed.109.069492openalex-snapshot
Targeting Prostate Cancer Cells In Vivo Using a Rapidly Internalizing Novel Human Single-Chain Antibody Fragment
inferred← citeshttps://doi.org/10.2967/jnumed.112.116624openalex-snapshot
99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer
inferred← citeshttps://doi.org/10.2967/jnumed.114.147413openalex-snapshot
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
inferred← citeshttps://doi.org/10.2967/jnumed.114.149062openalex-snapshot
Preclinical Evaluation of 86Y-Labeled Inhibitors of Prostate-Specific Membrane Antigen for Dosimetry Estimates
inferred← citeshttps://doi.org/10.2967/jnumed.115.155929openalex-snapshot
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen
inferred← citeshttps://doi.org/10.2967/jnumed.116.174300openalex-snapshot
(2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy
inferred← citeshttps://doi.org/10.2967/jnumed.116.175810openalex-snapshot
Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
inferred← citeshttps://doi.org/10.2967/jnumed.121.262989openalex-snapshot
18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
inferred← citeshttps://doi.org/10.2967/jnumed.123.266458openalex-snapshot
One Hundred Years of the Tracer Principle
showing the first 200 of 230 · page through all 230
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.